论文部分内容阅读
目的 总结尸肾移植 2 49例的经验。方法 分析 1992年 5月至 2 0 0 0年 4月 2 49例的临床资料 ,包括一般资料 ,组织配型 ,供肾情况 ,手术技术 ,免疫抑制剂的应用 ,术后并发症的发生情况等。结果 人 /肾存活率分别为术后 1个月 98% / 94.4% ,1a 92 .3% / 88.5 % ,3 a 82 .2 % / 78.2 % ,5 a 76 .5 % / 6 1.8%。结论 高质量的取肾和植肾术及良好的 HL A配型是提高存活率的基础 ,霉酚酸酯 (MMF)可降低急性排斥的发生率 ,合理的免疫抑制及感染的预防是提高存活率的关键。
Objective To summarize the experience of 2 49 cases of corpse kidney transplantation. Methods Clinical data of 492 cases from May 1992 to April 2000 were analyzed, including general information, tissue matching, kidney donation, operation technique, application of immunosuppressive agents and postoperative complications . Results The human / kidney survival rates were 98% / 94.4%, 1a 92.3% / 88.5%, 3 a 82.2% / 78.2%, 5 a 76.5% / 6 1.8% respectively at 1 month after operation. Conclusions High-quality renal and renal transplantation and good HLA matching are the basis for improving survival rate. Mycophenolate mofetil (MMF) can reduce the incidence of acute rejection, and reasonable immunosuppression and prevention of infection increase survival Rate the key.